TDACU: Translational Development Acquisition Corp. – Debt/Equity Composite Units Stock

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) -5.60
Book Value / Share n/a
Price / Book n/a
NCAV ($M) -179.95
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.97
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.09
Current Ratio 3.09

Balance Sheet (mrq) ($M)
Current Assets 0.65
Assets 175.00
Liabilities 180.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -0.20
Net Income -0.07

Cash Flow Statement (mra) ($M)
Cash From Operations -0.85
Cash from Investing -174.22
Cash from Financing 175.51

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-29 13G Magnetar Financial LLC 7.53

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 100 1,331 7.51
2025-05-07 300 2,481 12.09
2025-05-06 409 1,574 25.98
2025-05-05 175 2,000 8.75

(click for more detail)


Financial data and stock pages provided by
Fintel.io